These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

779 related articles for article (PubMed ID: 24113071)

  • 1. Development and characterization of a novel controlled release drug delivery system based on nanostructured lipid carriers gel for meloxicam.
    Khurana S; Jain NK; Bedi PM
    Life Sci; 2013 Nov; 93(21):763-72. PubMed ID: 24113071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoemulsion based gel for transdermal delivery of meloxicam: physico-chemical, mechanistic investigation.
    Khurana S; Jain NK; Bedi PM
    Life Sci; 2013 Mar; 92(6-7):383-92. PubMed ID: 23353874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and evaluation of solid lipid nanoparticles based nanogel for dermal delivery of meloxicam.
    Khurana S; Bedi PM; Jain NK
    Chem Phys Lipids; 2013; 175-176():65-72. PubMed ID: 23994283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanostructured lipid carriers based nanogel for meloxicam delivery: mechanistic, in-vivo and stability evaluation.
    Khurana S; Jain NK; Bedi PM
    Drug Dev Ind Pharm; 2015; 41(8):1368-75. PubMed ID: 25151872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanostructured lipid carriers (NLC) based controlled release topical gel of clobetasol propionate: design and in vivo characterization.
    Nagaich U; Gulati N
    Drug Deliv Transl Res; 2016 Jun; 6(3):289-98. PubMed ID: 27072979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanostructured lipid carriers (NLCs) versus solid lipid nanoparticles (SLNs) for topical delivery of meloxicam.
    Khalil RM; Abd-Elbary A; Kassem MA; Ghorab MM; Basha M
    Pharm Dev Technol; 2014 May; 19(3):304-14. PubMed ID: 23528038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation of meloxicam gel for topical application: In vitro and in vivo evaluation.
    Bachhav YG; Patravale VB
    Acta Pharm; 2010 Jun; 60(2):153-63. PubMed ID: 21134852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanostructured lipid carriers (NLC) based topical gel of flurbiprofen: design, characterization and in vivo evaluation.
    Han F; Yin R; Che X; Yuan J; Cui Y; Yin H; Li S
    Int J Pharm; 2012 Dec; 439(1-2):349-57. PubMed ID: 22989987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ion-pair formation combined with a penetration enhancer as a dual strategy to improve the transdermal delivery of meloxicam.
    Jiang Q; Wang J; Ma P; Liu C; Sun M; Sun Y; He Z
    Drug Deliv Transl Res; 2018 Feb; 8(1):64-72. PubMed ID: 29181834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and evaluation of meloxicam niosomes as vesicular carriers for enhanced skin delivery.
    El-Menshawe SF; Hussein AK
    Pharm Dev Technol; 2013; 18(4):779-86. PubMed ID: 21913880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.
    Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A
    Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bovine serum albumin-meloxicam nanoaggregates laden contact lenses for ophthalmic drug delivery in treatment of postcataract endophthalmitis.
    Zhang W; Zu D; Chen J; Peng J; Liu Y; Zhang H; Li S; Pan W
    Int J Pharm; 2014 Nov; 475(1-2):25-34. PubMed ID: 25158220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical Assessment of Steroidal Nanostructured Lipid Carriers Based Gels for Atopic Dermatitis: Optimization and Product Development.
    Nagaich U; Gulati N
    Curr Drug Deliv; 2018; 15(5):641-651. PubMed ID: 28925874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced transdermal delivery of lornoxicam by nanostructured lipid carrier gels modified with polyarginine peptide for treatment of carrageenan-induced rat paw edema.
    Gao S; Tian B; Han J; Zhang J; Shi Y; Lv Q; Li K
    Int J Nanomedicine; 2019; 14():6135-6150. PubMed ID: 31447556
    [No Abstract]   [Full Text] [Related]  

  • 15. Positively charged polymeric nanoparticles: application in improving therapeutic efficacy of meloxicam after oral administration.
    Khachane P; Date AA; Nagarsenker MS
    Pharmazie; 2011 May; 66(5):334-8. PubMed ID: 21699066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s).
    Garg NK; Sharma G; Singh B; Nirbhavane P; Tyagi RK; Shukla R; Katare OP
    Int J Pharm; 2017 Jan; 517(1-2):413-431. PubMed ID: 27956192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of novel ultradeformable liposomes: menthosomes, transfersomes and liposomes for enhancing skin permeation of meloxicam.
    Duangjit S; Obata Y; Sano H; Onuki Y; Opanasopit P; Ngawhirunpat T; Miyoshi T; Kato S; Takayama K
    Biol Pharm Bull; 2014; 37(2):239-47. PubMed ID: 24225259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elastic liposomes bearing meloxicam-beta-cyclodextrin for transdermal delivery.
    Jain SK; Gupta Y; Jain A; Amin S
    Curr Drug Deliv; 2008 Jul; 5(3):207-14. PubMed ID: 18673264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of dermal and transdermal delivery of meloxicam gels in rabbits.
    Patel M; Joshi A; Hassanzadeth H; Juluru R; Stagni G
    Drug Dev Ind Pharm; 2011 May; 37(5):613-7. PubMed ID: 21469950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanostructured lipid carriers as novel ophthalmic delivery system for mangiferin: improving in vivo ocular bioavailability.
    Liu R; Liu Z; Zhang C; Zhang B
    J Pharm Sci; 2012 Oct; 101(10):3833-44. PubMed ID: 22767401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.